Howard Hughes Medical Institute’s JPMorgan Chase JPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-588
Closed -$189K 275
2025
Q4
$189K Sell
588
-3
-0.5% -$929 0.11% 12
2025
Q3
$186K Sell
591
-14
-2% -$4.16K 0.11% 12
2025
Q2
$175K Buy
+605
New +$154K 0.07% 12
2017
Q3
Sell
-6,217
Closed -$568K 80
2017
Q2
$568K Buy
+6,217
New +$536K 0.1% 90
2014
Q2
Sell
-1,276
Closed -$77K 210
2014
Q1
$77K Sell
1,276
-99
-7% -$5.72K 0.01% 134
2013
Q4
$80K Buy
1,375
+458
+50% +$25.1K 0.01% 147
2013
Q3
$47K Sell
917
-458
-33% -$24.6K 0.01% 162
2013
Q2
$73K Buy
+1,375
New +$69.9K 0.02% 147

Other funds holding JPM

Howard Hughes Medical Institute's JPM Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of JPMorgan Chase (JPM) in Q1 2026, closing a stake of 588 shares — an estimated $189K sold.

Howard Hughes Medical Institute first reported a position in JPM in Q2 2013 and held it in 8 quarters. The position peaked at $568K in Q2 2017. 5,057 funds tracked by Wall St. Rank hold JPM as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining JPMorgan Chase position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 588 JPMorgan Chase shares in Q1 2026, an estimated $189K.
  • Howard Hughes Medical Institute first reported a position in JPMorgan Chase in Q2 2013 and held it in 8 quarters.
  • Howard Hughes Medical Institute's JPMorgan Chase position peaked at $568K in Q2 2017.
  • 5,057 funds tracked by Wall St. Rank held JPMorgan Chase as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.